In a report issued on August 3, Richard Close from Canaccord Genuity reiterated a rating on Castlight Health (NYSE: CSLT), with a price target of . The company’s shares closed on Friday at $4.30.
Castlight Health has an analyst consensus of Moderate Buy, with a price target consensus of $4.75.
Based on Castlight Health’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $32.1 million and GAAP net loss of $13.72 million. In comparison, last year the company earned revenue of $23.59 million and had a GAAP net loss of $16.69 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Castlight Health, Inc. engages in the provision of healthcare information technology solutions. It offers health benefits platforms which enables benefit leaders to communicate and measure their programs. The company was founded by Todd Y. Park, Bryan E. Roberts, and Giovanni M. Colella in January 2008 and is headquartered in San Francisco, CA.